ARTICLE | Company News
GENZ gets Fabrazyme FDA response
October 22, 2001 7:00 AM UTC
Genzyme (GENZ) received a second response letter from the FDA for its BLA for Fabrazyme agalsidase beta to treat Fabry disease. GENZ said the letter specifies additional data and information the FDA i...